Suneva Medical (Tiger Aesthetics)

Where Suneva fits

Suneva Medical, the San Diego company now operating under Tiger Aesthetics Medical, is not competing for your everyday syringe volume — it sells differentiation. Bellafill, its PMMA-collagen flagship, is the only filler on the US market with FDA approval backed by five-year safety and effectiveness data, indicated for nasolabial folds and, uniquely among fillers, moderate to severe atrophic acne scars. Alongside it sits Silhouette InstaLift, a resorbable thread system for non-surgical lifting.

For a med spa, that means Suneva is an additive relationship: you keep your HA and toxin vendors, and you add Bellafill to serve two patient types the rest of your menu can't — the correction patient tired of annual refills, and the acne-scar patient most injectable practices currently refer out.

What stands out

The clinical moat is real. 'The only FDA-approved five-year filler' is a claim no HA franchise can answer, and it converts a specific, high-intent patient. The acne-scar indication may be even more valuable commercially: it is an underserved market with strong word-of-mouth, and Bellafill gives you an on-label answer.

The economics per treatment are also compelling. Bellafill's wholesale cost is premium, but retail pricing per session runs well above HA norms, so even modest monthly volume adds meaningful revenue. Because results are semi-permanent, it tends to attract committed patients rather than deal-shoppers, and the threads line lets the same rep relationship support a second high-ticket, non-surgical offer.

Where it falls short

The biggest caveats are organizational and clinical. Suneva is a small company that has been through ownership churn, most recently landing under Tiger Aesthetics Medical. Practices have seen rep turnover and, in some territories, slower account support during the transition — worth pressure-testing with your local rep before committing inventory dollars.

Clinically, PMMA is unforgiving. Unlike HA, Bellafill cannot be dissolved with hyaluronidase, so injector skill, conservative technique, and patient selection matter far more than with a routine HA appointment. Suneva gates purchasing behind manufacturer training accordingly, and the bovine collagen component requires a pre-treatment skin test — both sensible, both friction. Onboarding is therefore slower than opening a typical filler account, and the two-product portfolio means Suneva will never consolidate your purchasing. Pricing, as across the category, is rep-negotiated and opaque; model your per-treatment margin explicitly rather than relying on list comparisons.

Who should choose it

Choose Suneva if you have experienced injectors, an established aesthetic patient base, and a strategy of premium differentiation. Bellafill is a genuine menu-expander: it captures long-duration correction patients and opens the acne-scar lane, both at price points that reward even low volume. It is a poor fit for new practices still building core HA competence, for teams without the patience for training and skin-test workflows, or for buyers who need a large, stable vendor organization behind every product. Treat it as a high-margin specialty line from a niche manufacturer in transition — and verify current rep coverage in your territory as part of diligence.